Can Dogs Have Alpha-Ketoglutarate Supplements for Aging?

By Dee Dugger, MS, DVM

✓ Medically reviewed by Dee Dugger, MS, DVM — August 31, 2026 For general education — not a substitute for veterinary care.

Longevity & Anti-Aging Trends · September 4, 2026 · 5 min read

Alpha-ketoglutarate has real mouse-lifespan data behind it — what it doesn't have yet is a single published dog trial, and that gap should shape how you use it.

Your feed has a new molecule to obsess over. Alpha-ketoglutarate — AKG, usually sold as calcium alpha-ketoglutarate — has spent the last two years moving from longevity-lab curiosity to something owners are dropping into their senior dog’s food alongside NAD+ chews and joint powders. The decision fork is simple to state and harder to answer: is there enough evidence to justify giving a metabolic intermediate to a healthy aging dog, or is this another case of a legitimate mouse finding getting stretched onto a species nobody has actually tested it in.

What alpha-ketoglutarate actually is

AKG is not exotic. It’s a normal intermediate in the tricarboxylic acid (TCA) cycle, the pathway every one of your dog’s cells uses to turn food into usable energy. Levels of it decline with age in multiple species, which is the biological hook researchers use to justify supplementing it back in. The calcium salt form, CaAKG, is the version most of the aging research has used, largely because it’s more stable and better tolerated than the free acid.

The mouse data is the real thing — and it’s still mouse data

This is where AKG earns its hype. A PubMed-indexed study out of the Buck Institute for Research on Aging fed middle-aged mice chow supplemented with calcium alpha-ketoglutarate and tracked lifespan and a battery of aging phenotypes — coat condition, grip strength, gait, body weight, frailty scoring. The effect was real but sex-specific: female mice on CaAKG saw meaningfully longer median lifespan and survival than untreated controls, with the improvement tied to lower systemic inflammatory markers. Male mice showed a smaller, less consistent benefit. That asymmetry matters — it’s one of the first things a careful reader should flag when a supplement company cites “the AKG longevity study” without the caveat.

Human data exists too, but it’s early. The ABLE trial, a placebo-controlled study of calcium alpha-ketoglutarate in adults aged 45 to 65, was designed specifically because so little controlled human evidence existed despite years of animal work; the PMC-hosted protocol paper is explicit that this is intervention research, not a confirmed outcome. Translate that caution downward to dogs and the honest read is: promising mechanism, strong rodent signal, no published canine trial as of this writing.

A 20-pound spaniel and a jar that didn’t get finished

A client brought in a 20-pound cocker spaniel, age 11, three weeks after starting an AKG powder she’d found through a supplement account she followed. She wanted to know if the slight drop in his stool consistency was the ingredient or the treats he’d been getting alongside it. We stopped the AKG for five days, stool normalized, and we restarted at half the labeled dose with no recurrence. Nothing about that rules AKG in or out as a longevity aid — it’s a single dog, and GI sensitivity to a new powder is common with almost any supplement change. What it does show is that “trending on TikTok” and “dosed appropriately for a 20-pound dog” are two different questions, and only one of them has good answers right now.

Where this collides with the rest of the longevity aisle

AKG rarely shows up alone. It’s frequently stacked with NAD+ precursors, resveratrol, or quercetin in the same “cellular aging” category, and it’s worth being precise about which of those actually has dog-relevant data behind it and which is still lab-bench evidence. Quercetin, for instance, is a flavonoid studied for antioxidant and immune-cell effects — one in-vitro paper on nematodes found that quercetin formulations, along with NAC and ascorbic acid, “did not affect the feeding behavior of the worms” at the concentrations tested, which is a narrow, model-organism finding, not a claim about dogs (evidence: Pharmaceuticals). Resveratrol has a similar pattern: an in-vitro study found that embryonic exposure to a resveratrol extract “accelerated pupation and adult emergence but shortened adult lifespan” in the model tested, at a concentration of 50 μg/ml — a reminder that even antioxidants generally treated as safe can behave in dose-dependent, organism-specific ways (evidence: Phytomedicine). None of this means these ingredients are unsafe for dogs at labeled doses; it means the evidence chain for most “longevity stack” ingredients is still built mostly from cells, worms, and mice, with the human and canine layers added later and thinner.

The edge case that changes the calculus: a dog already on other supplements

Here’s where it gets less theoretical. A 9-year-old, 68-pound Labrador on a joint chew, a fish-oil capsule, and a prescription for early kidney values is a genuinely different case than a healthy 6-year-old terrier. By day 10 of layering in an AKG powder on top of that stack, the question isn’t “does AKG work” — it’s whether anyone is tracking cumulative calcium load, since calcium alpha-ketoglutarate is, structurally, a calcium salt, and dogs with kidney or urinary stone history need that flagged before anything else gets added. This is the scenario where “ask your vet before adding a new longevity supplement” stops being boilerplate and starts being the actual clinical question, particularly for dogs with a hind leg weakness workup underway or any diagnosis that already touches calcium metabolism.

The bottom line

Keep supplements in the support-not-cure lane every time — that’s true for AKG the same as it’s true for every other molecule on this aisle. The mouse-lifespan data is genuinely one of the stronger findings in the longevity-supplement space, and the mechanism (TCA cycle intermediate, anti-inflammatory signaling) is plausible enough that I don’t dismiss it. But plausible mechanism plus rodent data is not the same as a dog trial, and nobody has published one. If you’re going to try it, do it as an add-on to a dog who’s otherwise stable, start at the lowest labeled dose, watch for GI upset in the first two weeks, and loop in your vet immediately if your dog has any kidney, calcium, or stone history. If your dog is already managing mobility changes, it’s worth ruling out the more common culprits first — see our checklist on dog back legs giving out or whether cold weather is making a senior dog seem stiffer before adding a new supplement to the pile. And if you’re already crushing chews into food to make dosing easier, check whether that actually holds up for the specific product you’re using, since not every formulation tolerates it.

The practical next step is not “buy the jar” or “skip it entirely.” It’s a five-minute conversation with your vet about your dog’s kidney values and current supplement stack, done before the first dose, not after three weeks of watching for a change that may or may not show up.